Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 14 studies | 39% ± 17% | |
epithelial cell | 12 studies | 40% ± 16% | |
type I pneumocyte | 10 studies | 28% ± 9% | |
ciliated cell | 8 studies | 26% ± 9% | |
goblet cell | 8 studies | 29% ± 9% | |
oligodendrocyte precursor cell | 8 studies | 36% ± 13% | |
club cell | 7 studies | 31% ± 13% | |
respiratory goblet cell | 7 studies | 27% ± 11% | |
basal cell | 6 studies | 27% ± 12% | |
secretory cell | 6 studies | 25% ± 7% | |
enterocyte | 6 studies | 28% ± 8% | |
squamous epithelial cell | 4 studies | 43% ± 22% | |
enteroendocrine cell | 4 studies | 30% ± 6% | |
intestinal crypt stem cell | 4 studies | 24% ± 5% | |
progenitor cell | 4 studies | 27% ± 8% | |
Schwann cell | 4 studies | 42% ± 18% | |
type II pneumocyte | 4 studies | 22% ± 8% | |
glial cell | 4 studies | 41% ± 19% | |
hepatocyte | 4 studies | 30% ± 23% | |
brush cell | 4 studies | 28% ± 3% | |
ionocyte | 3 studies | 17% ± 1% | |
transit amplifying cell | 3 studies | 24% ± 7% | |
luminal cell of prostate epithelium | 3 studies | 26% ± 7% | |
melanocyte | 3 studies | 27% ± 9% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 29% ± 9% | |
abnormal cell | 3 studies | 24% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 8729.63 | 226 / 226 | 96% | 80.54 | 389 / 406 |
prostate | 96% | 7072.05 | 235 / 245 | 99% | 120.10 | 497 / 502 |
stomach | 95% | 9527.83 | 340 / 359 | 98% | 128.23 | 280 / 286 |
intestine | 94% | 8695.37 | 908 / 966 | 98% | 127.88 | 517 / 527 |
pancreas | 100% | 6124.96 | 328 / 328 | 92% | 86.92 | 163 / 178 |
esophagus | 94% | 6666.59 | 1356 / 1445 | 90% | 85.78 | 165 / 183 |
kidney | 99% | 5060.07 | 88 / 89 | 84% | 73.98 | 754 / 901 |
skin | 72% | 10001.37 | 1305 / 1809 | 94% | 226.44 | 445 / 472 |
lung | 81% | 3394.93 | 467 / 578 | 85% | 71.68 | 985 / 1155 |
breast | 61% | 5458.16 | 278 / 459 | 99% | 166.78 | 1104 / 1118 |
bladder | 67% | 3608.33 | 14 / 21 | 90% | 85.08 | 454 / 504 |
thymus | 63% | 1463.63 | 410 / 653 | 59% | 26.39 | 355 / 605 |
brain | 68% | 3260.90 | 1793 / 2642 | 32% | 15.19 | 227 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.42 | 1 / 1 |
uterus | 12% | 372.33 | 20 / 170 | 81% | 56.33 | 374 / 459 |
eye | 0% | 0 | 0 / 0 | 86% | 71.35 | 69 / 80 |
ovary | 1% | 30.54 | 2 / 180 | 84% | 49.19 | 363 / 430 |
tonsil | 0% | 0 | 0 / 0 | 82% | 41.79 | 37 / 45 |
heart | 19% | 412.22 | 160 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 5% | 171.49 | 71 / 1335 | 0% | 0 | 0 / 0 |
adipose | 5% | 129.05 | 59 / 1204 | 0% | 0 | 0 / 0 |
muscle | 4% | 85.34 | 30 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 2% | 46.84 | 5 / 258 | 1% | 1.08 | 3 / 230 |
spleen | 0% | 12.59 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.59 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0038133 | Biological process | ERBB2-ERBB3 signaling pathway |
GO_0014037 | Biological process | Schwann cell differentiation |
GO_0055025 | Biological process | positive regulation of cardiac muscle tissue development |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0042552 | Biological process | myelination |
GO_0007507 | Biological process | heart development |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0070886 | Biological process | positive regulation of calcineurin-NFAT signaling cascade |
GO_0007275 | Biological process | multicellular organism development |
GO_0007162 | Biological process | negative regulation of cell adhesion |
GO_0042060 | Biological process | wound healing |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0022008 | Biological process | neurogenesis |
GO_0014044 | Biological process | Schwann cell development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0007422 | Biological process | peripheral nervous system development |
GO_0003197 | Biological process | endocardial cushion development |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_2000672 | Biological process | negative regulation of motor neuron apoptotic process |
GO_0097049 | Biological process | motor neuron apoptotic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0051048 | Biological process | negative regulation of secretion |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0021545 | Biological process | cranial nerve development |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0038143 | Cellular component | ERBB3:ERBB2 complex |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0038131 | Molecular function | neuregulin receptor activity |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0030296 | Molecular function | protein tyrosine kinase activator activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0043125 | Molecular function | ErbB-3 class receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0038132 | Molecular function | neuregulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ERBB3 |
Protein name | Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3) Erb-b2 receptor tyrosine kinase 3 (ErbB-3 R31) receptor protein-tyrosine kinase (EC 2.7.10.1) Erb-b2 receptor tyrosine kinase 3 Erb-b2 receptor tyrosine kinase 3 (cDNA FLJ43038 fis, clone BRTHA3002955, highly similar to Receptor tyrosine-protein kinase erbB-3) |
Synonyms | HER3 c-erbB-3 |
Description | FUNCTION: Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins. Binds to neuregulin-1 (NRG1) and is activated by it; ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase . May also be activated by CSPG5 . Involved in the regulation of myeloid cell differentiation . . |
Accessions | ENST00000683164.1 [P21860-4] F8VRL0 O75812 F8VW48 P21860 ENST00000267101.8 [P21860-1] F8VRI5 ENST00000411731.6 [P21860-2] ENST00000550828.1 ENST00000549061.5 ENST00000683059.1 [P21860-4] B4DGQ7 A0A2R8Y6T4 ENST00000683018.1 [P21860-4] ENST00000549282.5 ENST00000550869.5 B3KWG5 ENST00000549832.1 F8VYK4 ENST00000415288.6 [P21860-4] ENST00000551085.5 ENST00000643266.1 ENST00000550070.6 ENST00000551242.5 [P21860-3] |